Idrinol, capsules 250 mg 40 pcs

Meldonium is a structural analog of gamma-butyrobetaine, a substance that is present in every cell of the human body. Meldonium inhibits gamma-butyrobetaine hydroxygenase, reduces carnitine synthesis and transport of long-chain fatty acids through cell membranes, prevents accumulation of activated forms of unoxidized fatty acids in cells – acylcarnitine derivatives and acylkoenzyme A.

Indications

— as part of complex therapy for coronary artery disease (angina pectoris, myocardial infarction); chronic heart failure, dyshormonal cardiomyopathy;

Pharmacological effect

Meldonium is a structural analogue of gamma-butyrobetaine, a substance that is present in every cell of the human body. Meldonium suppresses gamma-butyrobetaine hydroxygenase, reduces the synthesis of carnitine and the transport of long-chain fatty acids through cell membranes, and prevents the accumulation in cells of activated forms of unoxidized fatty acids – derivatives of acylcarnitine and acyl coenzyme A.

Special instructions

Idrinol is not a first-line drug for acute coronary syndrome.

Active ingredient

Meldonium

Composition

Capsules 1 capsule. active substance:

Pregnancy

The safety of the drug during pregnancy has not been proven.

Contraindications

hypersensitivity; increased intracranial pressure (in case of impaired venous outflow and intracranial tumors); pregnancy; lactation period; children under 18 years of age.

Side Effects

From the cardiovascular system: rarely – tachycardia, decreased or increased blood pressure.

Interaction

Can be combined with antianginal drugs, anticoagulants, antiplatelet agents, antiarrhythmic drugs, diuretics, bronchodilators.

Overdose

Symptoms: decreased blood pressure, accompanied by headache, tachycardia, dizziness and general weakness.
Treatment: symptomatic.

Storage conditions

The drug should be stored out of the reach of children at a temperature not exceeding 25°C. Do not freeze.

Shelf life

3 years

Manufacturer

Olainfarm, Latvia